Filing Details

Accession Number:
0001181431-12-034422
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-06-04 17:23:26
Reporting Period:
2012-05-31
Filing Date:
2012-06-04
Accepted Time:
2012-06-04 17:23:26
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1113148 Infinity Pharmaceuticals Inc. INFI Pharmaceutical Preparations (2834) 330655706
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1300247 H Steven Holtzman C/O Infinity Pharmaceuticals, Inc.
780 Memorial Drive
Cambridge MA 02139
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2012-05-31 57,573 $13.01 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 3,945 Indirect By IRA
Footnotes
  1. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $13.00 to $13.15, inclusive. The reporting person undertakes to provide to Infinity Pharmaceuticals, Inc., any security holder of Infinity Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
  2. The reporting person no longer has a reportable beneficial interest in the shares of Infinity Pharmaceuticals, Inc. common stock owned by the Holtzman-Stewart 1996 Irrevocable Trust and included in the reporting person's prior ownership reports.